Evidence map›Paper›PMID 25403028›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2015

TSH elevations as the first laboratory evidence for pseudohypoparathyroidism type Ib (PHP-Ib).

Angelo Molinaro, Dov Tiosano, Rieko Takatani, Dionisios Chrysis, William Russell, Nikolas Koscielniak, Marie-Laure Kottler, Patrizia Agretti, Giuseppina De Marco, Petteri Ahtiainen and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Analysis of Multiple Families With Single Individuals Affected by Pseudohypoparathyroidism Type Ib (PHP1B) Reveals Only One Novel Maternally Inherited GNAS Deletion.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2016
    Trial
  2. Article
  3. Article
  4. Clinical and genetic characteristics for 4 patients with Type Ib pseudohypoparathyroidism.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Epidemiology and Diagnosis of Hypoparathyroidism.The Journal of clinical endocrinology and metabolism · 2016
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 7 countries.

Angelo MolinaroEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, University Hospital of Pisa, Pisa, Italy.
Dov Tiosano
Rieko Takatani
Dionisios Chrysis
William Russell
Nikolas Koscielniak
Marie-Laure Kottler
Patrizia Agretti
Giuseppina De Marco
Petteri Ahtiainen
Marta Christov
Outi Mäkitie
Massimo Tonacchera
Harald Jüppner
Harvard University · USAzienda Ospedaliera Universitaria Pisana · ITCentral Finland Health Care District · FICentre Hospitalier Universitaire de Caen · FRInstitute of Genetics · HUMassachusetts General Hospital · USRambam Health Care Campus · ILSaint Louis University · ESUniversity of Pisa · ITVanderbilt University · US

Funding

PTH/PTHRP RECEPTOR DEFECTS IN PSEUDOHYPOPARATHYROIDISMR01DK046718 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JUEPPNER, HARALD W. · 1993 to 2024
$6.0M
Dissecting the Mechanisms that control FGF23K08DK093608 · NIDDK · NEW YORK MEDICAL COLLEGE · PI CHRISTOV, MARTA · 2012 to 2016
$752k
NIDDK NIH HHS K08 DK093608NIDDK NIH HHS R01 DK046718NIDDK NIH HHS R01 DK 46718-20
6 · The paper itself

Abstract

Hypocalcemia and hyperphosphatemia because of resistance toward parathyroid hormone (PTH) in the proximal renal tubules are the most prominent abnormalities in patients affected by pseudohypoparathyroidism type Ib (PHP-Ib). In this rare disorder, which is caused by GNAS methylation changes, resistance can occur toward other hormones, such as thyroid-stimulating hormone (TSH), that mediate their actions through G protein-coupled receptors. However, these additional laboratory abnormalities are usually not recognized until PTH-resistant hypocalcemia becomes clinically apparent. We now describe four pediatric patients, first diagnosed with subclinical or overt hypothyroidism between the ages of 0.2 and 15 years, who developed overt PTH-resistance 3 to 20 years later. Although anti-thyroperoxidase (anti-TPO) antibodies provided a plausible explanation for hypothyroidism in one of these patients, this and two other patients revealed broad epigenetic GNAS abnormalities, which included loss of methylation (LOM) at exons AS, XL, and A/B, and gain of methylation at exon NESP55; ie, findings consistent with PHP-Ib. LOM at GNAS exon A/B alone led in the fourth patient to the identification of a maternally inherited 3-kb STX16 deletion, a well-established cause of autosomal dominant PHP-Ib. Although GNAS methylation changes were not detected in additional pediatric and adult patients with subclinical hypothyroidism (23 pediatric and 39 adult cases), hypothyroidism can obviously be the initial finding in PHP-Ib patients. One should therefore consider measuring PTH, along with calcium and phosphate, in patients with unexplained hypothyroidism for extended periods of time to avoid hypocalcemia and associated clinical complications.

Indexed as

AdultChild, PreschoolChromosomes, Human, Pair 20Epigenesis, GeneticExonsFemaleHumansInfantInfant, NewbornMalePseudohypoparathyroidismSyntaxin 16ThyrotropinYoung AdultSTX16 protein, humanSyntaxin 16ThyrotropinEPIGENETICSGNASHYPOTHYROIDISMPSEUDOHYPOPARATHYROIDISMPTH

Identifiers

PMID25403028
PMCPMC4401615
OpenAlexW2134156006

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.